EQL Pharma

EQL Pharma is a publicly traded Swedish company with a mission to simplify and streamline the pharmaceutical value chain to deliver affordable, high-quality generic and specialty drugs. Since its founding in 2008, it has established a focused commercial presence in the Nordics through an asset-light model of in-licensing, development, and external manufacturing. Its strategy centers on identifying and capitalizing on market opportunities with weak generic competition or specific therapeutic needs, aiming for profitable growth without strict geographic or therapeutic limitations.

EQL Pharma's platform is its optimized operational model for generic drug development, focusing on efficient product identification, bioequivalence study management, regulatory submission, and supply chain orchestration with external partners.

EQL Pharma competes against global generic giants and European players by focusing on niche markets with weak competition. Its competitive edge stems from regional expertise in the Nordics, an agile asset-light model, and a strategy targeting complex products rather than competing solely on scale in commoditized generics.